- Home
- PINS vs ARWR Comparison
PINS vs ARWR Comparison
Compare PINS & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PINS | ARWR |
|---|---|---|
| Founded | 2008 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 12.4B |
| IPO Year | 2019 | 2009 |
Fundamental Metrics
Financial Performance| Metric | PINS | ARWR |
|---|---|---|
| Price | $21.41 | $62.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 38 | 14 |
| Target Price | $29.05 | ★ $107.23 |
| AVG Volume (30 Days) | ★ 10.3M | 2.0M |
| Earning Date | 11-03-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 99.80 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,221,767,000.00 | $16,142,321.00 |
| Revenue This Year | $16.40 | N/A |
| Revenue Next Year | $12.98 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.79 | N/A |
| 52 Week Low | $13.84 | $34.61 |
| 52 Week High | $35.42 | $95.49 |
Technical Indicators
Market Signals| Indicator | PINS | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 62.14 | 32.23 |
| Support Level | $17.76 | $60.87 |
| Resistance Level | $22.37 | $66.37 |
| Average True Range (ATR) | 0.67 | 2.41 |
| MACD | 0.41 | 0.03 |
| Stochastic Oscillator | 96.06 | 25.44 |
Price Performance
Historical ComparisonAbout PINS Pinterest Inc.
Pinterest is a social media platform with a focus on product and idea discovery. Pinterest users, or pinners, can leverage the platform as they go about gathering ideas on topics such as home improvement, fashion, cooking, and travel. The company has more than 500 million monthly active users, two thirds of whom are female. Pinterest generates revenue by selling digital ads on its platform. While the platform's user base spans the globe, the vast majority of its revenue stems from ads shown to North American users.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.